Nautilus Biotechnology, Inc. (NAUT)

NASDAQ: NAUT · IEX Real-Time Price · USD

2.610

-0.090 (-3.33%)

At close: Jul 19, 2024, 12:00 AM

2.600

-0.010 (-0.38%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Nautilus Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	327	374	225	643	208
Market Cap Growth	6.33%	66.41%	-65.10%	208.97%	-
Enterprise Value	179	235	70	327	136
PE Ratio	-	-5.87	-3.88	-12.78	-13.33
PB Ratio	1.31	1.41	0.71	1.77	-7.00
P/FCF Ratio	-6.36	-6.90	-4.66	-15.49	-13.96
P/OCF Ratio	-6.63	-7.22	-4.90	-16.39	-14.87
EV/EBITDA Ratio	-3.59	-4.05	-1.29	-6.90	-10.26
EV/EBIT Ratio	-3.26	-3.69	-1.21	-6.51	-8.72
EV/FCF Ratio	-3.80	-4.34	-1.46	-7.89	-9.13
Debt / Equity Ratio	0.13	0.13	0.10	0.08	-0.16
Debt / EBITDA Ratio	-0.55	-0.60	-0.56	-0.63	-0.36
Debt / FCF Ratio	-0.58	-0.64	-0.63	-0.72	-0.32
Quick Ratio	19.69	19.01	27.16	59.49	25.43
Current Ratio	20.09	19.39	27.57	60.09	25.73
Return on Equity (ROE)	-24.90%	-22.40%	-17.50%	-18.40%	253.10%
Return on Assets (ROA)	-21.70%	-19.60%	-15.80%	-16.00%	-26.50%
Return on Capital (ROIC)	-28.15%	-25.39%	-18.43%	-12.83%	63.11%
Earnings Yield	-20.63%	-17.04%	-25.80%	-7.82%	-7.50%
FCF Yield	-17.69%	-14.50%	-21.44%	-6.45%	-7.17%
Buyback Yield / Dilution	-0.44%	-0.26%	-47.51%	-190.36%	-379.48%
Total Shareholder Return	-0.44%	-0.26%	-47.51%	-190.36%	-379.48%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).